Restructure Medicare & Medicaid: In Addition to Life Expectancy, USA Falls
Epstein Suite indexes the text; the original document lives at its official source. We don't host the original file — view it on the official release to read it in full.
View the original on the official releaseDocument text
Text is machine OCR and may contain errors. Confirm against the original source above.
Restructure Medicare & Medicaid: In Addition to Life Expectancy, USA Falls
Behind OECD Averages in Many Other Health Indicators
OECD USA Ranking
2007 Health Indicators USA Median (1 = Best, 30 = Worst)
RED = Below Average
Obesity (% of total population) 34 15 30
Infant Mortality (per 1,000 live births) 7 4 27
Medical Resources Available (per 1,000 population)
Total Hospital Beds 3 6 25
Practicing Physicians 2 3 22
Doctors’ Consultations per Year 4, 6 19
MRI Machines* (per million population) 26 9 1
Cause of Death (per 100,000 population)
Heart Attack 216 178 22
Respiratory Diseases 60 45 21
Diabetes 20 12 20
Cancer 158 159 14
Stroke 33 45 8
KP Note: *MRI is Magnetic Resonance Imaging. Source: OECD.
i USA Inc. | What Might a Turnaround Expert Consider? 317
Restructure Medicare & Medicaid: Effectiveness Research Could Improve
Efficiency (i.e., Outputs Track Inputs)
e Comparative Effectiveness evaluates different options for treating a condition for a
specific set of patients’
— Either relative benefits and risks of various treatment options (technology
assessment, evidence-based medicine), or
— Both clinical effectiveness and relative cost (cost-benefit analysis).
e Without rigorous data about comparative effectiveness, according to the CBO:
— Treatment decisions often depend on anecdotal evidence, conjecture, and the
experience/judgment of involved physicians.
— Treatments and types of care vary widely from one area of the country to another.
e To affect healthcare spending meaningfully, comparative effectiveness must alter
doctor and patient behavior, potentially through reimbursement scheme changes, the
CBO notes.
e Note that by law, Medicare is effectively precluded from considering costs when
making coverage decisions.
K P Source: “Research on the Comparative Effectiveness of Medical Treatments”, A CBO Paper, December 2007.
www.kpcb.com ne. at Might a Turnaround Expert Consider?
B kpeb USA Inc. | What Might a T dE Consider? 318
HOUSE_OVERSIGHT_021000
Have a question about what this document contains?
Ask the documents